This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Mayo Foundation for Medical Education and Research. Active years: 2018.
Company Filing History:
Years Active: 2018
Title: Yi Lin - Innovator in Immune Subtype Treatment
Introduction
Yi Lin is a notable inventor based in Rochester, MN (US). He has made significant contributions to the field of medical treatment through his innovative approaches to assessing and treating patients based on immune subtypes. His work is particularly relevant in the context of personalized medicine, where understanding individual immune profiles can lead to better health outcomes.
Latest Patents
Yi Lin holds a patent for a method titled "Treating patients based on immune subtypes." This patent provides methods and materials for treating patients following an assessment of immune subtypes, such as evaluating peripheral blood phenotypes. The patent outlines methods for treating mammals with medical conditions after assessing their levels of CD14+/DR− cells and CD4+ cells. This classification helps determine whether a mammal is likely to experience a favorable or unfavorable medical outcome based on these immune cell levels. Yi Lin has 1 patent to his name.
Career Highlights
Yi Lin is associated with the Mayo Foundation for Medical Education and Research, where he applies his expertise in immunology and patient treatment. His work at this prestigious institution underscores his commitment to advancing medical science and improving patient care through innovative research.
Collaborations
Some of Yi Lin's notable coworkers include Allan B Dietz and Michael P Gustafson. Their collaboration reflects a team-oriented approach to research and development in the medical field.
Conclusion
Yi Lin's contributions to the treatment of patients based on immune subtypes highlight the importance of personalized medicine in modern healthcare. His innovative patent and work at the Mayo Foundation for Medical Education and Research demonstrate his dedication to improving patient outcomes through scientific advancements.